Fri 19'th Jan 2018
RXI Pharmaceuticals Corporation Stock Analysis
Technical stock analysis for Fri 19'th Jan 2018
|Shorts||4.92% ( 2017-12-29 )|
RXI Pharmaceuticals Corporation lies in the lower of a very wide and falling trend in the short term, and this will normally pose a very good buying opportunity. A break down the bottom trend line at $4.07 will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -14.69% during the next 3 months and, with 90% probability hold a price between $3.47 and $5.50 at the end of this period.
Some negative signals were issued as well, and these may have some influence on the near short-term development. RXI Pharmaceuticals Corporation holds a buysignal from the short-term moving average; at the same time, however, a sales signal from the long-term average. Since the longterm average is above the short-term average there is a general sales signal in the stock. On further gains, the stock will meet resistance from the long-term moving average at $5.48. On a fall, the stock will find some support from the short-term average at $4.41. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sales signal and strengthen the general signal. A sales signal was issued from a pivot top point on Wednesday January 17, 2018, which indicates further falls until a new bottom pivot has been found. Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.
Relative Strength Index (RSI)
The stock currently holds a RSI14 at 26 and is oversold on RSI14. The stock being oversold is no guarantee for instant reaction up as some stocks may be oversold for a long time. It is important to review the previous RSI-history to get an indication of the RSI-sensitiveness.
Support & Resistance
RXI Pharmaceuticals Corporation finds support from accumulated volume at $4.41. On the upside the stock meets some resistance just above today's level from accumulated volume at $4.50, $4.69 and $4.69.
The stock is about to test the resistance from accumulated volume at $4.50 and this may cause the stock to take a minor break or get into a more sideways move for a few days.
This stock may move much during a day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.29 between high and low, or 6.81%. For the last week the stock has had a daily average volatility of 10.11%.
RXI Pharmaceuticals Corporation is oversold on RSI14 (26). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.
Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.
Very Low Low Medium High Very High
Short Sell RXII CFDs with Plus500
Your capital is at risk.
Important: Plus500 doesn't offer signals and it is a CFD service.
Plus500UK Ltd is authorised and regulated by the Financial Conduct Authority (FRN 509909).
Access these features
Auto portfolios gaining up to 30%
Top 5 Candidates in all Lists
Ultimate List Builder